The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced Wednesday. It’s the first step in an anticipated global rollout that could protect millions – although it’s unclear how many in the U.S. and abroad will get access to the powerful new option.

While a vaccine to prevent HIV still is needed, some experts say the shot — a drug called lenacapvir — could be the next best thing. It nearly eliminated new infections in two groundbreaking studies of people at high risk, better than daily preventive pills they can forget to take.

“This really has the possibility of ending HIV transmission,” said Greg Millett, public policy director at amfAR, The Foundation for AIDS Research.

  • ShoeThrower@lemmy.zip
    link
    fedilink
    arrow-up
    28
    ·
    1 day ago

    In the US it will cost $30,000 per year of treatment, while a generic version could be sold for $40 and still be massively profitable.

    • Blumpkinhead@lemmy.world
      link
      fedilink
      arrow-up
      18
      arrow-down
      1
      ·
      1 day ago

      Jesus Christ, I thought you were just being cynical, but they’re really planning on charging that much. These fucking people, I swear…

  • Archangel1313@lemmy.ca
    link
    fedilink
    arrow-up
    62
    arrow-down
    1
    ·
    2 days ago

    Just waiting for RFK jr to revoke this approval on the basis that it can’t prevent gay people from doing poppers, so it must not work.

  • Bluefalcon@discuss.tchncs.de
    link
    fedilink
    arrow-up
    17
    arrow-down
    2
    ·
    2 days ago

    Quick poll, Under this current admin, the stance by RFK jr., and with their open stance of LGBQT+ community; will you trust them enough to take this vaccine?

    I really am interested to see the responses.

    • medgremlin@midwest.social
      link
      fedilink
      arrow-up
      22
      ·
      2 days ago

      Unfortunately, it’s not a vaccine. It’s similar to the Depo Provera shot in that it releases the active medication over a long time from a gel injected into a muscle, but it doesn’t grant immunity when the drug is not present in the system the way a vaccine would.

  • smeg@infosec.pub
    link
    fedilink
    English
    arrow-up
    6
    arrow-down
    55
    ·
    2 days ago

    Twice a year, because making a single shot vaccine won’t give you repeat customers.

    • jeffw@lemmy.worldM
      link
      fedilink
      arrow-up
      44
      arrow-down
      3
      ·
      2 days ago

      Imagine the business unit telling the scientists “sorry, we can’t put out your vaccine, please alter it” and the scientists replying with anything other than “go fuck yourself, I’m selling this for millions to someone else” lol

      There’s no conspiracy to prevent an HIV vaccine

      • entwine413@lemm.ee
        link
        fedilink
        arrow-up
        23
        arrow-down
        4
        ·
        edit-2
        2 days ago

        I mean, the scientists could not legally sell it to someone else. They’re employed by the pharmaceutical company who owns their research.

        But you’re right, being the first company to beat HIV would be worth way more than whatever profits you’re making off the drug. Same with cancer.

        • albert180@piefed.social
          link
          fedilink
          English
          arrow-up
          9
          arrow-down
          2
          ·
          2 days ago

          You overestimate wildly how much pharmaceutical companies Vs Universities contribute to the R&D to a new drug

          • jeffw@lemmy.worldM
            link
            fedilink
            arrow-up
            4
            arrow-down
            1
            ·
            2 days ago

            lol who downvoted this. I work in healthcare and a bunch of our research if funded by pharmaceutical companies. It’s not like they do it all in house

        • jeffw@lemmy.worldM
          link
          fedilink
          arrow-up
          3
          arrow-down
          1
          ·
          2 days ago

          If they say “we won’t pursue your drug you discovered” then you 100% can pursue it elsewhere

            • jeffw@lemmy.worldM
              link
              fedilink
              arrow-up
              1
              ·
              1 day ago

              You’re right, it is more complicated because there is usually more than one party involved. Regardless, if anything were available like a true vaccine, someone would piggyback on that research and make bank

      • vampire@lemmy.dbzer0.com
        link
        fedilink
        English
        arrow-up
        17
        ·
        2 days ago

        My Nurse Practitioner was telling me yesterday they are studying the right dosage to make it just 1 shot a year. So hopefully on the way when they figure that out

        • frezik@midwest.social
          link
          fedilink
          arrow-up
          1
          ·
          edit-2
          22 hours ago

          Yeah, this stuff takes time to work out. As long as the side effects aren’t a big deal, they might err on the side of too much.

          Covid vaccines were something of an exception because they were motivated and infections were widespread. Lots of chances to get good data. Treatments for other diseases don’t have those advantages.

          The HPV vax, for example, was released in 2016 on a three dose schedule. There’s some studies out there that argue two doses would be plenty, but it’s not a consensus, either. That’s after almost a decade.

          PrEP is already keeping HIV infection rates pretty low, at least in rich countries where there’s money to do these studies. Not going to be good data on dose schedules for many, many years. Maybe even decades.

    • entwine413@lemm.ee
      link
      fedilink
      arrow-up
      20
      ·
      2 days ago

      Do you know for a fact there’s not a medical reason for splitting it into two doses?

    • medgremlin@midwest.social
      link
      fedilink
      arrow-up
      10
      ·
      2 days ago

      It isn’t a vaccine. It’s a slow-release compound like the Depo Provera shot that is used for birth control. It’s an amazing option for people who have trouble with daily pills for any reason and it’s more effective than the PreP pills available on the market today.

    • jordanlund@lemmy.worldM
      link
      fedilink
      arrow-up
      9
      ·
      2 days ago

      FTA:

      “U.S. list price, meaning before insurance, is $28,218 a year”

      Same price regardless, 1 or 2 shots. It’s per year, not per shot.

      • TipRing@lemmy.world
        link
        fedilink
        English
        arrow-up
        9
        ·
        2 days ago

        What’s shitty is that this drug could damn near wipe out HIV if it were accessible to everyone who needed it.

        But I guess we can’t have that.

      • albert180@piefed.social
        link
        fedilink
        English
        arrow-up
        5
        ·
        edit-2
        2 days ago

        Nearly nobody will pay sticker price though. They have to set an absolute bullshit price, so the Pharmacy Benefit Managers can “negotiate” a huge “discount” (=real price) to show how much savings and value they create.

        It’s the same with costs for Hospitals in the US (huge Bullshit Sticker Price, insurance negotiates a “discount” for the employer, and gets a percentage for the service and savings they provide)

    • gravitas_deficiency@sh.itjust.works
      cake
      link
      fedilink
      English
      arrow-up
      3
      ·
      2 days ago

      You clearly have not read the article, and thus don’t understand that the prophylactic nature of the shot requires a 6-month administration cycle. Like when you get a flu shot, or a Covid vaccine. Or (with current PrEP meds) a pill that you take every day.

      Read the article.